Croatia Osiguranje DD (ZAG:CROS) Research & Development: €0.0 Mil (TTM As of Mar. 2026)


ZAG:CROS Croatia Osiguranje DD ZAG:CROS
35 GF Score
Price €3,460.00
GF Value €1,925.71
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Croatia Osiguranje DD Research & Development?

Croatia Osiguranje DD ZAG:CROS +1.76% 35 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates ZAG:CROS with a GF Score™ of 35/100 and a GF Value™ of €1,925.71 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Croatia Osiguranje DD's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

Croatia Osiguranje DD  (ZAG:CROS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Croatia Osiguranje DD Research & Development Related Terms

Croatia Osiguranje DD Research & Development Historical Data

* Premium members only.

The historical data trend for Croatia Osiguranje DD's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Croatia Osiguranje DD Research & Development Chart

Croatia Osiguranje DD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Croatia Osiguranje DD Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ZAG:CROS
35GF Score
Croatia Osiguranje DD ZAG:CROS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Croatia Osiguranje DD Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Croatia Osiguranje DD (ZAG:CROS) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Croatia Osiguranje DD and its competitors.
Is Croatia Osiguranje DD's Research & Development too high?
Croatia Osiguranje DD's current Research & Development is €0.0 Mil. Overall, Croatia Osiguranje DD has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Croatia Osiguranje DD's Research & Development compare to CB and PGR?
Croatia Osiguranje DD's Research & Development of €0.0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Croatia Osiguranje DD and its competitors. Croatia Osiguranje DD's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Croatia Osiguranje DD stock overvalued right now?
Based on GuruFocus' analysis, Croatia Osiguranje DD (ZAG:CROS) is currently considered Significantly Overvalued. The stock's GF Value™ is €1,925.71, compared to a current price of €3,460.00 — trading 79.7% above its estimated fair value. The current Research & Development is €0.0 Mil. Croatia Osiguranje DD's overall GF Score™ is 35/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Croatia Osiguranje DD (ZAG:CROS), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Croatia Osiguranje DD (ZAG:CROS) Overvalued in 2026?

Based on GuruFocus' analysis, Croatia Osiguranje DD stock appears to be overvalued. The current stock price of €3,460.00 is trading 79.7% above its estimated GF Value™ of €1,925.71. GuruFocus considers Croatia Osiguranje DD to be Significantly Overvalued.

Key valuation signals for ZAG:CROS:

  • Research & Development: €0.0 Mil
  • GF Value™: €1,925.71 vs. price of €3,460.00 (79.7% above fair value)
  • GF Score™: 35/100 with 7 warning signs

No single metric tells the full story. See the ZAG:CROS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Croatia Osiguranje DD Business Description

Address Vatroslava Jagica 33, Zagreb, HRV, 10000
Croatia Osiguranje DD is engaged in non-life and life insurance business and reinsurance business in the non-life insurance group in the territory of the Republic of Croatia. At the same time, the Group operates in the territories of Northern Macedonia, Bosnia and Herzegovina, and Serbia. Insurance and reinsurance activities are the Company's core business segments. In addition to insurance and reinsurance activities, CO Group companies also perform the following activities: pension fund management, performance of vehicle testing, provision of healthcare services, and real estate management. The segments include: Non-life and Life Insurance segments.
35GF Score

Get the complete analysis for ZAG:CROS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3,460.00
Price
€1,925.71
GF Value